Civil Litigation
Nov. 20, 2019
FDA asbestos find in talc may reopen lost cases, plaintiffs’ attorneys say
Plaintiffs’ attorneys are hoping the U.S. Food and Drug Administration’s recent finding of asbestos in Johnson & Johnson baby powder will be elemental to winning the battle over whether talc is linked to cancer and possibly restarting trials their clients have lost.
Plaintiffs' attorneys are hoping the U.S. Food and Drug Administration's recent finding of asbestos in Johnson & Johnson baby powder will be elemental to winning the battle over whether talc is linked to cancer and possibly restarting trials their clients have lost.
Litigation has ping-ponged between eye-popping jury verdicts as high as $4.7 billion to strings of defense wins. There are 2,000 talc mesothelioma cases, on top of ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Civil Litigation, Health Care & Hospital Law
Johnson & Johnson wins LA baby powder case
By Blaise Scemama
Consumer Law, Civil Litigation
Ending talc sales unlikely to aid J&J defense, plaintiffs say
By Justin Kloczko
